These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 7631608)

  • 1. Predictors of mortality in patients with sustained ventricular tachycardias or ventricular fibrillation and depressed left ventricular function: importance of beta-blockade.
    Szabó BM; Crijns HJ; Wiesfeld AC; van Veldhuisen DJ; Hillege HL; Lie KI
    Am Heart J; 1995 Aug; 130(2):281-6. PubMed ID: 7631608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic factors after sustained ventricular fibrillation or tachycardia. A multivariate study apropos of 160 cases].
    Fleurant E; Lacroix D; Klug D; Warembourg H; Kacet S; Lekieffre J
    Arch Mal Coeur Vaiss; 1996 Apr; 89(4):435-44. PubMed ID: 8763003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stratification of sudden death risk in patients receiving long-term amiodarone treatment for sustained ventricular tachycardia or ventricular fibrillation.
    Olson PJ; Woelfel A; Simpson RJ; Foster JR
    Am J Cardiol; 1993 Apr; 71(10):823-6. PubMed ID: 8456761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry).
    Piccini JP; Hranitzky PM; Kilaru R; Rouleau JL; White HD; Aylward PE; Van de Werf F; Solomon SD; Califf RM; Velazquez EJ
    Am J Cardiol; 2008 Dec; 102(11):1427-32. PubMed ID: 19026290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The amiodarone-beta blockers combination could represent an alternative treatment in patients at risk for sudden death in which a benefit from implantable defibrillators has not been clearly demonstrated].
    Alboni P
    Ital Heart J Suppl; 2002 Mar; 3(3):337-43. PubMed ID: 12040849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis of patients with sustained ventricular tachycardia and of survivors of cardiac arrest not inducible by programmed stimulation.
    Andresen D; Steinbeck G; Brüggemann T; Haberl R; Fink L; Schröder R
    Am J Cardiol; 1992 Nov; 70(15):1250-4. PubMed ID: 1442574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study.
    Giorgberidze I; Saksena S; Krol RB; Munsif AN; Kolettis T; Mathew P; Varanasi S; Prakash A; Delfaut P; Lewis CB
    Am J Cardiol; 1997 Sep; 80(5B):3F-9F. PubMed ID: 9291444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic utility of T-wave alternans in a real-world population of patients with left ventricular dysfunction: the PREVENT-SCD study.
    Shizuta S; Ando K; Nobuyoshi M; Ikeda T; Yoshino H; Hiramatsu S; Kazatani Y; Yamashiro K; Okajima K; Kajiya T; Kobayashi Y; Kato T; Fujii S; Mitsudo K; Inoue K; Ito H; Haruna Y; Doi T; Nishio Y; Ozasa N; Nishiyama K; Kita T; Morimoto T; Kimura T;
    Clin Res Cardiol; 2012 Feb; 101(2):89-99. PubMed ID: 21960418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-blocker use and survival in patients with ventricular fibrillation or symptomatic ventricular tachycardia: the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial.
    Exner DV; Reiffel JA; Epstein AE; Ledingham R; Reiter MJ; Yao Q; Duff HJ; Follmann D; Schron E; Greene HL; Carlson MD; Brodsky MA; Akiyama T; Baessler C; Anderson JL
    J Am Coll Cardiol; 1999 Aug; 34(2):325-33. PubMed ID: 10440140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk stratification and prognosis of patients treated with amiodarone for malignant ventricular tachyarrhythmias after myocardial infarction.
    Proclemer A; Facchin D; Vanuzzo D; Feruglio GA
    Cardiovasc Drugs Ther; 1993 Aug; 7(4):683-9. PubMed ID: 8241012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional Longitudinal Deformation Improves Prediction of Ventricular Tachyarrhythmias in Patients With Heart Failure With Reduced Ejection Fraction: A MADIT-CRT Substudy (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy).
    Biering-Sørensen T; Knappe D; Pouleur AC; Claggett B; Wang PJ; Moss AJ; Solomon SD; Kutyifa V
    Circ Cardiovasc Imaging; 2017 Jan; 10(1):. PubMed ID: 28003221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical usefulness of electrophysiologic testing in patients with ventricular tachycardia and chronic chagasic cardiomyopathy treated with amiodarone or sotalol.
    Leite LR; Fenelon G; Simoes A; Silva GG; Friedman PA; de Paola AA
    J Cardiovasc Electrophysiol; 2003 Jun; 14(6):567-73. PubMed ID: 12875414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of amiodarone therapy on mortality in patients with left ventricular dysfunction and asymptomatic complex ventricular arrhythmias: Argentine Pilot Study of Sudden Death and Amiodarone (EPAMSA).
    Garguichevich JJ; Ramos JL; Gambarte A; Gentile A; Hauad S; Scapin O; Sirena J; Tibaldi M; Toplikar J
    Am Heart J; 1995 Sep; 130(3 Pt 1):494-500. PubMed ID: 7661066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term clinical outcome of ventricular tachycardia or fibrillation treated with amiodarone.
    McGovern B; Garan H; Malacoff RF; DiMarco JP; Grant G; Sellers TD; Ruskin JN
    Am J Cardiol; 1984 Jun; 53(11):1558-63. PubMed ID: 6731300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging for identifying patients with cardiac sarcoidosis and preserved or mildly reduced left ventricular function at risk of ventricular arrhythmias.
    Crawford T; Mueller G; Sarsam S; Prasitdumrong H; Chaiyen N; Gu X; Schuller J; Kron J; Nour KA; Cheng A; Ji SY; Feinstein S; Gupta S; Ilg K; Sinno M; Abu-Hashish S; Al-Mallah M; Sauer WH; Ellenbogen K; Morady F; Bogun F
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1109-15. PubMed ID: 25266311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.
    Klein H; Auricchio A; Reek S; Geller C
    Am J Cardiol; 1999 Mar; 83(5B):91D-97D. PubMed ID: 10089848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term treatment of ventricular tachycardia with amiodarone in presence of severe left ventricular dysfunction.
    Burckhardt D; Robertson A; Hoffmann A; Pfisterer M
    J Clin Pharmacol; 1991 Nov; 31(11):1105-8. PubMed ID: 1753016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Risk stratification and long-term therapy with amiodarone in patients with idiopathic dilated cardiomyopathy].
    Zehender M; Faber T; Furtwängler A; Hohnloser S; Meinertz T; Just H
    Z Kardiol; 1992 Dec; 81(12):704-9. PubMed ID: 1492440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.